In: BMC Psychiatry, 18 (2018), Nr. 388. pp. 1-13. ISSN 1471-244X

Preview

PDF, English - main document Download (735kB) | Lizenz: Sequential treatment of ADHD in mother and child (AIMAC study): importance of the treatment phases for intervention success in a randomized trial by Hautmann, Christopher ; Döpfner, Manfred ; Katzmann, Josepha ; Schürmann, Stephanie ; Wolff Metternich-Kaizman, Tanja ; Jaite, Charlotte ; Kappel, Viola ; Geissler, Julia ; Warnke, Andreas ; Jacob, Christian ; Hennighausen, Klaus ; Haack-Dees, Barbara ; Schneider-Momm, Katja ; Philipsen, Alexandra ; Matthies, Swantje ; Rösler, Michael ; Retz, Wolfgang ; von Gontard, Alexander ; Sobanski, Esther ; Alm, Barbara ; Hohmann, Sarah ; Häge, Alexander ; Poustka, Luise ; Colla, Michael ; Gentschow, Laura ; Freitag, Christine M. ; Becker, Katja ; Jans, Thomas underlies the terms of Creative Commons Attribution 4.0

Abstract

Background: The efficacy of parent-child training (PCT) regarding child symptoms may be reduced if the mother has attention-deficit/hyperactivity disorder (ADHD). The AIMAC study (ADHD in Mothers and Children) aimed to compensate for the deteriorating effect of parental psychopathology by treating the mother (Step 1) before the beginning of PCT (Step 2). This secondary analysis was particularly concerned with the additional effect of the Step 2 PCT on child symptoms after the Step 1 treatment.

Methods: The analysis included 143 mothers and children (aged 6–12 years) both diagnosed with ADHD. The study design was a two-stage, two-arm parallel group trial (Step 1 treatment group [TG]: intensive treatment of the mother including psychotherapy and pharmacotherapy; Step 1 control group [CG]: supportive counseling only for mother; Step 2 TG and CG: PCT). Single- and multi-group analyses with piecewise linear latent growth curve models were applied to test for the effects of group and phase. Child symptoms (e.g., ADHD symptoms, disruptive behavior) were rated by three informants (blinded clinician, mother, teacher).

Results: Children in the TG showed a stronger improvement of their disruptive behavior as rated by mothers than those in the CG during Step 1 (Step 1: TG vs. CG). In the CG, according to reports of the blinded clinician and the mother, the reduction of children’s disruptive behavior was stronger during Step 2 than during Step 1 (CG: Step 1 vs. Step 2). In the TG, improvement of child outcome did not differ across treatment steps (TG: Step 1 vs. Step 2).

Conclusions: Intensive treatment of the mother including pharmacotherapy and psychotherapy may have small positive effects on the child’s disruptive behavior. PCT may be a valid treatment option for children with ADHD regarding disruptive behavior, even if mothers are not intensively treated beforehand.

Trial registration: ISRCTN registry ISRCTN73911400. Registered: 29 March 2007.